跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,051 条关于
“Dystrophic EB”
全部
2,051
临床试验
1,315
药物
185
机构
249
资讯
302
12个月前
DEBRA Research and Nonsense Therapeutics Form ReadOn Therapeutics to Advance Epidermolysis Bullosa Treatments
去年
Long-term EASE Trial Shows Promise: Birch Triterpenes Demonstrates Sustained Wound Reduction in Epidermolysis Bullosa Patients
9个月前
Xinnate Advances TCP-25 for Epidermolysis Bullosa with FDA IND Approval and First Clinical Publication
去年
Relief Therapeutics' RLF-TD011 Shows Promise in Epidermolysis Bullosa Trial
去年
Stanford Medicine Gene Therapy Skin Grafts Show 81% Healing Rate in Phase 3 Epidermolysis Bullosa Trial
9天前
Redasemtide Clears Ulcer Endpoint in Dystrophic EB but Misses Primary Endpoint in Global Phase 2 Acute Ischemic Stroke Trial
去年
FDA Upgrades Xinnate's TCP-25 Trial for Epidermolysis Bullosa to Registrational Status
去年
FDA Grants Rare Pediatric Disease Designation to Relief Therapeutics' EB Treatment RLF-TD011
去年
Paradigm Therapeutics Secures $12.5M Investment to Advance Novel Epidermolysis Bullosa Treatment
去年
Abeona Therapeutics Resubmits BLA to FDA for Gene Therapy Pz-Cel in Dystrophic Epidermolysis Bullosa
第 1 页,共 31 页
上一页
下一页